Skip to main content
OpenTrials

Clinical trial condition

Oligodendroglioma

Explore clinical trials studying Oligodendroglioma. Study availability and eligibility vary by location and protocol.

299 public trials 22 recruiting studies
Refine in advanced search Browse all conditions

Oligodendroglioma trial results

Completed

Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary Glioma

NCT00027625

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +17 more
Locations
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
  • UCSF Comprehensive Cancer Center San Francisco, California, United States
  • Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States
  • Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Irinotecan in Treating Patients With Progressive or Recurrent Malignant Glioma

NCT00003616

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +15 more
Locations
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
  • UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
View Trial Details
Completed

Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma

NCT00010049

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +22 more
Locations
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
  • UCSF Comprehensive Cancer Center San Francisco, California, United States
  • Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States
  • Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation Therapy

NCT00004868

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +20 more
Locations
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
  • UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States
  • Neuro-Oncology Branch Bethesda, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Fenretinide in Treating Patients With Recurrent Malignant Glioma

NCT00006080

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +15 more
Locations
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
  • UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States
  • Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

CCI-779 in Treating Patients With Malignant Glioma

NCT00022724

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +17 more
Locations
  • Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States
  • UCSF Comprehensive Cancer Center San Francisco, California, United States
  • Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States
  • Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors

NCT00025675

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +22 more
Locations
  • Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States
  • UCSF Comprehensive Cancer Center San Francisco, California, United States
  • Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States
  • NCI - Neuro-Oncology Branch Bethesda, Maryland, United States
View Trial Details
Completed

Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma

NCT00002569

Conditions
Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, Glioma, +11 more
Locations
  • MBCCOP - Gulf Coast Mobile, Alabama, United States
  • CCOP - Greater Phoenix Phoenix, Arizona, United States
  • Veterans Affairs Medical Center - Phoenix (Carl T. Hayden) Phoenix, Arizona, United States
  • Veterans Affairs Medical Center - Tucson Tucson, Arizona, United States
View all 95 locations
View Trial Details
Completed

Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme

NCT01648348

Conditions
Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, +23 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Saint Jude Medical Center Fullerton, California, United States
  • Saint Joseph Hospital - Orange Orange, California, United States
  • Sharp Memorial Hospital San Diego, California, United States
View all 308 locations
View Trial Details
Completed

Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor

NCT01985256

Conditions
Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma, +19 more
Locations
  • UC Irivine Irvine, California, United States
  • UCLA Los Angeles, California, United States
  • UC San Diego, Moores Cancer Center San Diego, California, United States
  • Henry Ford Hospital Detroit, Michigan, United States
View Trial Details

Related conditions